Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded. As of April 2, 2026, the State Street SPDR S&P Biotech ETF (NYSE:XBI) ...

Focused on immunology therapies, this clinical-stage biotech reported significant insider selling amid a challenging year for ...

One of the world’s largest biotech companies is closing its only office in the Bay Area. Pfizer is shutting down its office ...

Tetra Pak and Lund University launch Biotech Heights, a hub for food and material biotechnology, enabling start-ups and researchers to collaborate on sustainable solutions.

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced it has filed its Annual Report on Form 10-K for the year ended ...

Shares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than smaller speculative names. That structure can offer more earnings visibility, but ...

Looking back on biotechnology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Incyte ...

1.1a Congress must establish a National Biotechnology Coordination Office (NBCO) within the Executive Office of the President with a director, appointed by the President, who would coordinate ...

Hello, I’m Ricki Lee, and this is The Capital Compass. Today we’re taking a look at Kraig Biocraft Laboratories (USOTC:KBLB), ...

Plant Biotechnology is a critical field at the intersection of sustainable agriculture, environmental management, and industrial innovation. Despite the ...

Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology ...

View Lixte Biotechnology Holdings, Inc. LIXT stock quote prices, financial information, real-time forecasts, and company news from CNN.